← Back to Screener
Veradermics, Incorporated (MANE)
Price$101.51
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (4W)-5.06%
VGM Score77.21
Market Capitalization$4.22B
All Metrics
Book Value / Share (Quarterly)$10.46
Price vs S&P 500 (YTD)157.07%
EPS (TTM)$-3.19
10-Day Avg Trading Volume0.49M
EPS Excl Extra (TTM)$-3.19
EPS (Annual)$-2.00
ROI (Annual)-48.79%
Cash / Share (Quarterly)$10.47
ROA (Last FY)-45.86%
EBITD / Share (TTM)$-3.30
Cash Flow / Share (Annual)$-2.04
P/B Ratio10.79x
P/B Ratio (Quarterly)6.04x
Net Income / Employee (Annual)$-3,333,100
Net Interest Coverage (TTM)-253.69x
EPS Incl Extra (Annual)$-2.00
Current Ratio (Annual)16.66x
Quick Ratio (Quarterly)58.46x
3-Month Avg Trading Volume0.54M
Revenue / Employee (TTM)$0
52-Week High$117.71
EPS Excl Extra (Annual)$-2.00
Quick Ratio (Annual)16.05x
13-Week Price Return135.17%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)59.12x
Enterprise Value$4.05B
Revenue / Employee (Annual)$0
Cash / Share (Annual)$4.04
3-Month Return Std Dev117.74%
Net Income / Employee (TTM)$-4,629,900
ROE (Last FY)-48.79%
EPS Basic Excl Extra (Annual)$-2.00
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-3.19
Revenue / Share (Annual)$0.00
Year-to-Date Return167.31%
5-Day Price Return-0.70%
EPS Normalized (Annual)$-2.00
Month-to-Date Return1.93%
EBITD / Share (Annual)$-2.06
LT Debt / Equity (Annual)0.00x
EPS Basic Excl Extra (TTM)$-3.19
Price vs S&P 500 (13W)125.42%
Beta-0.51x
Revenue / Share (TTM)$0.00
52-Week Low$32.00
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-1.32est. -0.67
Analyst Recommendations
Apr 2026
May 2026
4.40
4.40
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MANEVeradermics, Incorporated | — | — | B | $101.51 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Veradermics Inc is a clinical-stage biopharmaceutical company developing therapeutics for aesthetic and dermatological conditions. The company addresses treatment gaps in high-prevalence skin disorders with novel therapeutic approaches.